FRA:BIG1 • DE000BGAG981
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIO-GATE AG (BIG1.DE).
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.99M -3.94% | 7.245M 20.96% | 7.053M -2.66% | 7.497M 6.30% | 8.109M 8.16% | 9.231M 13.84% | |
| EBITDA YoY % growth | -1.542M -351.26% | -1.323M 14.20% | -1.299M 1.84% | -963.9K 25.80% | -204K 78.84% | 321.3K 257.50% | |
| EBIT YoY % growth | -1.781M -233.10% | -1.59M 10.72% | -1.603M -0.80% | -1.255M 21.74% | -499.8K 60.16% | -25.5K 94.90% | |
| Operating Margin | -29.74% | -21.95% | -22.73% | -16.73% | -6.16% | -0.28% | |
| EPS YoY % growth | N/A | N/A -100.00% | N/A -37.50% | -0.12 30.30% | -0.05 60.87% | -0.01 88.89% |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
8 analysts have analysed BIG1.DE and the average price target is 3.06 EUR. This implies a price increase of 381.89% is expected in the next year compared to the current price of 0.635.
The expected long term growth rate for BIO-GATE AG (BIG1.DE) is 7.3%.